Ttbio Corp.

Taipei Exchange 6493.TWO

Ttbio Corp. Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD -304.31 K

Ttbio Corp. Net Cash Used Provided By Financing Activities is USD -304.31 K for the year ending December 31, 2023, a -125.55% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • Ttbio Corp. Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD 1.19 M, a 1,251.00% change year over year.
  • Ttbio Corp. Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD -103.46 K, a 96.90% change year over year.
  • Ttbio Corp. Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD -3.34 M, a -151.99% change year over year.
  • Ttbio Corp. Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD -1.32 M.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
Taipei Exchange: 6493.TWO

Ttbio Corp.

CEO Shu Rong Yang
IPO Date Jan. 8, 2015
Location
Headquarters No. 07, 6th Road Industry Park
Employees 101
Sector Health Care
Industries
Medical Instruments Pharmaceuticals
Description

Ttbio Corp. manufactures, sells, and maintains medical devices under the TTBIO brand name in Taiwan and internationally. The company offers high and low speed hand piece products, dental spare parts, service rotors, maintenance units, and electric hand piece systems. It also provides precision machined parts and components to various industries, including medical, automotive, aerospace, security, computer components, maintenance parts, and custom machining. The company was founded in 2012 and is based in Taichung, Taiwan.

StockViz Staff

January 15, 2025

Any question? Send us an email